Overcoming Barriers to Care - Diagnosis and Referrals
This panel discussion (part 1) presents on overcoming barriers to come for lung cancer, and includes a pulmonologist, a radiation oncologist, a thoracic surgeon, and a medical oncologist. The panel covers lung cancer screening, diagnostic workup and staging for lung cancer patients, appropriate tissue analysis including molecular workup, and treatment options. This will be followed by a discussion and open question session.
The activity is designed to meet the interests of radiation oncologists, medical oncologists, surgeons, pathologists, internists, family practitioners and radiation oncology residents.
Upon completion of this activity, learners should be able to:
- Discuss low dose CT lung cancer screening with all eligible patients.
- Refer patients to the appropriate specialists for lung cancer care.
- Order appropriate staging assessments and other necessary workup to allow timely initiation of treatment.
- Megan Daly, MD, is employed by UC Davis and has research funding from the NIH, Department of Defense, American Cancer Society, EMD Serono, Genentech and Merck. She is also a consultant with Triptych Health Partners and on the Advisory Board of Boston Scientific.
- Dawn Owen, PhD, MD, is employed by the Mayo Clinic has no financial relationships with a commercial interest.
Gregory Kalemkerian, MD, is employed by the University of Michigan and has research funding from Merck, Takeda, Blueprint, Daiichi-Sankyo and Cullinan.
Janani Reisenauer, MD, is employed by the Mayo Clinic and has research funding from Intuitive Surgical.
Michael Simoff, MD, is employed by the Henry Ford Health System and has research funding and is a consultant GongwinBioPharm.He is also a consultant with Intuitive Surgical and on the Advisory Board of Varian Medical Systems.
Megan Daly, MD, is employed by UC Davis and has research funding from the NIH, Department of Defense, American Cancer Society, EMD Serono, Genentech and Merck. She is also a consultant with Triptych Health Partners and on the Advisory Board of Boston Scientific.
The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.00 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.